Alethio Therapeutics: Funding, Investors & Team (Nov 2026)
Alethiomics is a biotech company harnessing the power of single-cell multi-omic technology to discover & develop treatment for blood cancer.
Alethio Therapeutics has raised $90.0M across 1 funding round on record, the most recent a Series A of $90.0M announced in Nov 2026.
That round is above the $65M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Alethio Therapeutics Company Profile and Key Stats
Latest funding round on record: Nov 2026.
Alethio Therapeutics Funding Rounds
Alethio Therapeutics Investors
Alethio Therapeutics Funding Compared to Other Biotechnology Startups
Alethio Therapeutics' latest round of $90.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Alethio Therapeutics in Biotechnology and Abingdon-on-thames
Companies Similar to Alethio Therapeutics
NovaGo Therapeutics is a Swiss biotech company developing human antibody therapeutics to promote regeneration…
Boulevard Bio is a biotechnology company founded by Deerfield Management that develops novel therapies for…
Mentari Therapeutics is a biotechnology company developing therapies for the prevention of migraine.
Syngenis Labs is committed to helping businesses and research organizations with their diagnostic and…
Mindmax is a frontier human intelligence laboratory: building tools and technologies to amplify the human…
FluoRok is changing the way fluorochemicals are manufactured on a global scale.
T-Therapeutics is a next-generation T cell receptor (TCR) company spun off from the University of Cambridge.
Supa provides property management services for residential, commercial, and mixed-use buildings.
AI Credit analysis & Risk monitoring platform for Banks, Business lenders and Credit teams
Tallia provides AI software for tax research, drafting, document review, and project workflows.
It is our mission to become the global leader in financial markets infrastructure for ETP primary markets
Bit.bio specializes in the fields of coding and biology that determine the identity of every human cell.…
Alethio Therapeutics Funding FAQs
What does Alethio Therapeutics do?
Alethiomics is a biotech company harnessing the power of single-cell multi-omic technology to discover & develop treatment for blood cancer.
How much funding has Alethio Therapeutics raised?
Alethio Therapeutics has raised $90.0M across 1 round on record. The most recent is a Series A of $90.0M announced in Nov 2026.
When did Alethio Therapeutics last raise funding?
Alethio Therapeutics' most recent funding round on record is a Series A of $90.0M, announced in Nov 2026.
Who has invested in Alethio Therapeutics?
Investors on record for Alethio Therapeutics include RA Capital Management, Sofinnova Partners, Oxford Science Enterprises, University of Oxford, Cancer Research Horizons.
Where is Alethio Therapeutics headquartered?
Alethio Therapeutics is based in Abingdon-on-thames, United Kingdom.
How many employees does Alethio Therapeutics have?
Alethio Therapeutics is in the 1-10 employee band.
When was Alethio Therapeutics founded?
Alethio Therapeutics was founded in 2021.
How does Alethio Therapeutics' funding compare to other Biotechnology startups?
Alethio Therapeutics' latest round of $90.0M is above the $65M median round size for Biotechnology companies on FundedIQ across 6 tracked companies over the last two years.
About FundedIQ's Alethio Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Alethio Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.